STD/HIV prevention intervention: Efficacy, effectiveness and population impact

Sexually Transmitted Infections

Volumn 84, Issue SUPPL. 2, 2008, Pages

  Aral, Sevgi O ^a   Blanchard, James ^b   Lipshutz, Judy ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b National Collaborating Centre for Infectious Diseases   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSTITUTION; SEXUALLY TRANSMITTED DISEASE; SHORT SURVEY;

COMMUNICABLE DISEASE CONTROL; HIV INFECTIONS; HUMANS; PATIENT COMPLIANCE; PROGRAM EVALUATION; SEXUALLY TRANSMITTED DISEASES;

EID: 53549112183     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2008.033613     Document Type: Short Survey

References (21)

1. Global HIV Prevention Working Group. Bringing HIV prevention to scale: an urgent global priority. 2007. www. globalhivprevention.org (accessed 21 August 2008).
2. Manhart LE, Holmes KK. Randomized controlled trials of individual-level, population-level, and multilevel interventions for preventing sexually transmitted infections: what has worked? J Infect Dis 2005;191 (Suppl 1):S7-24.
3. Marley J. Efficacy, effectiveness, efficiency. Aust Prescriber 2000;23:114-5.
4. Kramer MS. Randomized trials and public health interventions: time to end the scientific double standard. Clin Perinatal 2003;330:351-61.
5. Oakley A. A historical perspective on the use of randomized trials in social science settings. Crime and Delinquency 2000;46:315-29.
6. Barreto ML. Efficacy, effectiveness, and the evaluation of public health interventions. J Epidemiol Community Health 2005;59:345-6.
7. Gray RH, Wawer MJ. Randomised trials of HIV prevention. Lancet 2007;370:200-1.
8. Pitisuttithum P, Gilbert P, Gurwith M, et al. Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand. J Infect Dis 2006;194:1661-71.
9. Check E. Scientists rethink approach to HIV gels. Nature 2007;446:12.
10. Peterson L, Taylor D, Roddy R, et al. Tenofovir disoproxil fumerate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trial. PLoS Clin Trials 2007;e27.
11. Padian NS, van der Straten A, Ramjee G, the MIRA Team. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomized controlled trial. Lancet 2007;370:251-61.
12. Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomized controlled trial. Lancet 2007;369:643-56.
13. Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomized trial. Lancet 2007;368:657-66.
14. Auvert B, Taljaard D, Lagarde E, et al. Randomized controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial. PLoS Med 2005;2:e298.
15. Hayes RJ, Alexander NDE, Bennet S, et al. Design and analysis issues in cluster-randomized trials of interventions against infectious diseases. Stat Methods Med Res 2000;9:95.
16. Rietmeijer CA, Gandelman AA. From best practices to better practice: adopting model behavioral interventions in the real world of STD/HIV prevention. In: Behavioral interventions for prevention and control of sexually transmitted diseases. In: Aral SO, Douglas JM Jr, eds. New York: Springer Science+ Business Media, 2007:500-14.
17. Glasgow RE, Lichtenstein E, Marcus AC. Why don't we see more translation of health promotion research to practice? Rethinking the efficacy-to-effectiveness transition. Am J Public Health 2003;93:1261-7.
18. Aral SO. Sexually transmitted disease prevention: from efficacy-to-effectiveness; from effectiveness-to-impact. Presented at the 17th Meeting of the International Society for STD Research (ISSTDR) and the 10th International Union against STIs (IUSTI); Seattle, Washington, 29 July 2007.
19. St Louis ME, Holmes KK. Conceptual framework of STD/HIV prevention and control. In: Holmes KK, Sparling PF, Mardh P-A, et al, eds. Sexually transmitted diseases. 3rd ed. New York: McGraw-Hill, 1999:1239-53.
20. Aral SO, Lipshutz JA, Douglas JM Jr. Introduction. In: Aral SO, Douglas JM Jr, eds. Behavioral interventions for prevention and control of sexually transmitted diseases. New York: Springer Science+ Business Media, 2007:ix-xviii.
21. Cole BL, Fielding JE. Health impact assessment: a tool to help policy makers understand health beyond health care. Annu Rev Public Health 2007;28:393-412.